Stock IGX INTELGENX TECHNOLOGIES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company IntelGenx Technologies Corp. Toronto S.E.

Equities

IGX

US45822R1014

Pharmaceuticals

End-of-day quote Toronto S.E.
Other stock markets
 06:00:00 2021-10-17 pm EDT 		5-day change 1st Jan Change
0.78 CAD +9.86% Intraday chart for IntelGenx Technologies Corp. +50.00% +173.68%
Apr. 08 Intelgenx Announces First Parkinson?S Disease Patients Dosed with Montelukast Versafilm® in Phase 2 ?Montpark? Clinical Trial CI
Apr. 05 IntelGenx Updates Status of Buprenorphine Buccal Film ANDA MT

Business Summary

IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, allows for pharmaceutical products that address unmet medical needs. It provides comprehensive pharmaceuticals services to pharmaceutical partners, including research and development (R&D), analytical method development, clinical monitoring, IP and regulatory services. Its manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production. Its product portfolio includes Migraine (Rizatriptan), Erectile Dysfunction (Tadalafil), Schizophrenia (Lozapine), Neurodegenerative, Opioid Dependence (Buprenorphine / Naloxone) and others.

Sales per Business

USD in Million2022Weight2023Weight Delta
Novel Oral Thin Film
100.0 %
1 100.0 % 1 100.0 % +9.37%

Sales per region

USD in Million2022Weight2023Weight Delta
Europe
80.8 %
1 73.8 % 1 80.8 % +19.83%
United States
18.6 %
0 15.3 % 0 18.6 % +33.10%
Canada
0.6 %
0 10.9 % 0 0.6 % -94.23%

Managers

Managers TitleAgeSince
Dwight Gorham CEO
 Chief Executive Officer 66 23-04-12
André Godin DFI
 Director of Finance/CFO 61 15-07-19
Horst Zerbe CHM
 Chairman 77 06-03-31
Nadine Paiement CTO
 Chief Tech/Sci/R&D Officer 47 05-05-31
Stephen John Kilmer IRC
 Investor Relations Contact - -
Tommy Kenny LAW
 General Counsel 37 15-12-31
David Kideckel PRN
 Corporate Officer/Principal - 23-03-19
Ingrid Zerbe SEC
 Corporate Secretary 69 06-03-31

Members of the board

Members of the board TitleAgeSince
Horst Zerbe CHM
 Chairman 77 06-03-31
Mark Nawacki BRD
 Director/Board Member 54 16-08-08
Bernd Melchers BRD
 Director/Board Member 72 09-04-07
Clemens Mayr BRD
 Director/Board Member 55 15-08-04
Ryan Barrett BRD
 Director/Board Member 43 Dec. 01
Monika Trzcinska BRD
 Director/Board Member 57 22-05-09
Sahil Kirpekar BRD
 Director/Board Member 38 Dec. 01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 174,658,096 135,542,895 ( 77.60 %) 0 77.60 %

Shareholders

NameEquities%Valuation
ATAI LIFE SCIENCES N.V.
21.36 %
37,300,000 21.36 % 7 M $
Ingrid Zerbe
0.3923 %
685,238 0.3923 % 120 602 $
Horst Zerbe
0.2107 %
368,064 0.2107 % 64 779 $
André Godin
0.1146 %
200,171 0.1146 % 35 230 $
J. Boudreau
0.1002 %
175,000 0.1002 % 30 800 $
Tommy Kenny
0.0958 %
167,250 0.0958 % 29 436 $
Bernd Melchers
0.0687 %
120,000 0.0687 % 21 120 $
Dana Matzen
0.0487 %
85,000 0.0487 % 14 960 $
Karen Kalayajian
0.0286 %
50,000 0.0286 % 8 800 $
David Kideckel
0.000000 %
0 0.000000 % - $
NameEquities%Valuation
Ingrid Zerbe
-
5,158,221 - 907 847 $
Horst Zerbe
-
4,238,680 - 746 008 $

Company contact information

IntelGenx Technologies Corp.

6420 Abrams

H4S 1Y2, Ville Saint-Laurent

+514 331 7440

http://www.intelgenx.com
address IntelGenx Technologies Corp.(IGX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.15
Average target price
-
Consensus

Sector Generic Pharmaceuticals

1st Jan change Capi.
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+18.59% 22.25B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.49% 14.39B
CIPLA LIMITED Stock Cipla Limited
+12.83% 13.55B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.02% 11.27B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.80% 6.95B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.35% 5.01B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-5.36% 4.51B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IGXT Stock
  4. IGX Stock
  5. Company IntelGenx Technologies Corp.